Opinion

Liberating time in the Economy of Attention

December 30, 2012

Pharmaceutical marketing is now operating in a new landscape--the Economy of Attention

Tomorrow's biopharma industry: new biotech products or higher operational efficiency--or both?

December 30, 2012

Abbott's spinout of AbbVie offers lessons

Another go at medication adherence

November 01, 2012

A managed services approach to sales and marketing

October 30, 2012

Applying the managed services model to commercial operations can result in dramatic savings as pharma companies globalize

BeSafeRx: FDA helping consumers avoid risks of online prescription drug purchases

October 30, 2012

Complex supply chains demand a holistic approach to protect patients

August 29, 2012

The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity

In the evolving world of pharma compliance, The PDMA Sharing Conference provides answers

August 29, 2012

Tectonic shifts in the product-security debate

August 29, 2012

Industry is not waiting for action in Washington

The clear and present danger of counterfeit drugs

July 18, 2012

Prospects for international policing of counterfeit drugs is dim

Packaging, serialization and medication adherence: the coming connection

July 18, 2012

Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare